5 Why do oestrogens prevent bone loss? (Q37070450)

18 August 2017

1 reference

title

Why do oestrogens prevent bone loss? (English)

1 reference

18 August 2017

5 Why do oestrogens prevent bone loss? (English)

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

2 December 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822821

2 December 2022

author name string

R. Lindsay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1822821

2 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1822821

2 December 2022

publication date

1 December 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:S0950355205802913?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

https://api.elsevier.com/content/article/PII:S0950355205802913?httpAccept=text/plain

2 December 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

Bailliere's clinical obstetrics and gynaecology

2 December 2022

published in

1 reference

18 August 2017

5

1 reference

18 August 2017

4

1 reference

18 August 2017

837-852

1 reference

Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

POSTMENOPAUSAL OSTEOPOROSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Skeletal mass and body composition in marathon runners

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Biochemical effects of 17 beta-estradiol on UMR106 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

The effects of long-term estrogen on hysterectomized women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Estrogens, bone loss and preservation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Prediction of rapid bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Screening procedure for women at risk of developing postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Evidence of estrogen receptors in normal human osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Long-term estrogen replacement therapy prevents bone loss and fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Rate of spinal trabecular bone loss in normal perimenopausal women: CT measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

The predictive value of fracture, disease, and falling tendency for fragility fractures in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Appropriate use of bone densitometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

An interleukin 1 like factor stimulates bone resorption in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Calcium supplements: Practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Prospective trial of oestrogen and calcium in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Age and bone mass as predictors of fracture in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

The contribution of bone loss to postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

An epidemiologic study of hip fracture in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Bone response to termination of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Prevention of spinal osteoporosis in oophorectomised women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Endogenous oestrogen and bone loss following oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Bone mass and body composition in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Menopausal estrogen therapy and hip fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Effect of sex hormones on bone in primary osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Detection of prefracture spinal osteoporosis using bone mineral absorptiometry

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Sex steroids and bone mass. A study of changes about the time of menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Determinants of bone density in normal women: risk factors for future osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Prediction of osteoporotic fractures in the general population by a fracture risk score. A 9-year follow-up among middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980291-3

7 January 2021

The effect of hormones on osteogenesis in man

4

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

2 December 2022

Oestrogens and Cancer

21

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

Menopausal changes in bone remodeling

2 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

Estrogen treatment of patients with established postmenopausal osteoporosis

2 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal Women

2 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

The minimum effective dose of estrogen for prevention of postmenopausal bone loss

2 December 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis

2 December 2022

69

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis

2 December 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release

2 December 2022

72

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80291-3

2 December 2022

Identifiers

1 reference

18 August 2017

1 reference